Schedule 13G ownership disclosure
RTI Biologics, Inc.
Security class unavailable · CUSIP: 74975N105
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,852,567
- Percent of class
- 6.0700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001609251-19-000002
- Form type
- SC 13G
- Filer
- Krensavage Asset Management, LLC
- CIK
- CIK 1609251
- Filed
- Feb 14, 2019
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership